v3.25.2
Financial instrument (Tables)
11 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2025
IfrsStatementLineItems [Line Items]    
Schedule of financial assets and liabilities

The following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments to which they are assigned, and therefore by the measurement basis:

   2025 
   USD 
     
Financial assets     
At amortised cost     
Cash on hand   1 
      
Financial liabilities     
At amortised cost     
Other payables and accrued expenses   18,503 
 
Alps Life Science Inc [Member]    
IfrsStatementLineItems [Line Items]    
Schedule of financial assets and liabilities  

The following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments to which they are assigned, and therefore by the measurement basis:

   2025   2024 
   USD   USD 
         
Financial assets          
At amortised cost          
Trade receivables   45,528    74,016 
Other receivables and deposits   267,146    200,920 
Amount due from associates   18,435    2,145 
Cash and bank balances   318,932    460,467 
           
Financial assets   650,041    737,548 

 

 

29. Financial instrument (Cont’d)

 

The following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments to which they are assigned, and therefore by the measurement basis: (Cont’d)

 

   2025   2024 
   USD   USD 
         
Financial liabilities          
At amortised cost          
Trade payables   321,350    175,599 
Other payables and accruals   864,910    849,451 
Amount due to associates   20,763    - 
Amount due to directors   5,972,257    3,610,711 
Hire purchase liabilities   -    7,260 
Lease liabilities   961,875    500,308 
           
Financial liabilities   8,141,155    5,143,329 
Schedule of maturity profile of the group’s financial liabilities  

The table below summarises the maturity profile of the Group’s financial liabilities at the end of the reporting period based on undiscounted contractual payments:

 

   Interest rate   Total carrying
amount
   On demand or
within 1 year
   Within 2 to 5 years   Total undiscounted cash flow 
   %   USD   USD   USD   USD 
                     
2025                         
Non-interest bearing:                         
Trade payables   -    321,350    321,350    -    321,350 
Other payables and accruals   -    878,421    878,421    -    878,421 
Amount due to associates   -    20,763    20,763    -    20,763 
Amount due to directors   -    5,972,257    5,972,257    -    5,972,257 
                          
Interest bearing:                         
Lease liabilities   6.65    961,875    499,557    535,578    1,035,135 
                          
         8,154,666    7,692,348    535,578    8,227,926 

 

 

29. Financial instrument (Cont’d)

 

(ii)Liquidity risk (Cont’d)

 

Analysis of financial instruments by remaining contractual maturities (Cont’d)

 

The table below summarises the maturity profile of the Group’s financial liabilities at the end of the reporting period based on undiscounted contractual payments: (Cont’d)

 

   Interest rate   Total carrying amount   On demand or
within 1 year
   Within 2 to 5 years   Total undiscounted cash flow 
   %   USD   USD   USD   USD 
                     
2024                         
Non-interest bearing:                         
Trade payables   -    175,599    175,599    -    175,599 
Other payables and accruals   -    956,063    956,063    -    956,063 
Amount due to directors   -    3,610,711    3,610,711    -    3,610,711 
                          
Interest bearing:                         
Hire purchase liabilities   4.55    7,260    7,384    -    7,384 
Lease liabilities   7.04    500,308    329,071    202,421    531,492 
                          
         5,249,941    5,078,828    202,421    5,281,249 
Schedule of financial assets and liabilities  

Summarised financial information of Cilo Cybin is set out below. The summarised financial information represents the amount in the financial statements of the associate and not the Group’s share of those amounts.

Schedule of financial information represents the amount in the financial statements

   2025   2024 
   USD   USD 
Statement of financial position          
Non-current assets   198,858    - 
Current assets   3,139,920    3,354,690 
           
Total assets   3,338,778    3,354,690 
           
Non-current liabilities   (173,968)   - 
Current liabilities   (114,958)   (593,538)
           
Total liabilities   (288,926)   (593,538)
           
Net assets of the associate   3,049,852    2,761,152 
           
Statement of comprehensive income          
Revenue for the financial year   256,858    229,058 
           
(Loss)/Profit for the financial year   (31,156)   21,809 
           
Share of (loss)/profit of the associate   (12,618)   8,833